Related Experiment Videos
[Malignant neoplasms and kidney transplantation]
N Serrallach1, L L Riera, E Franco
1Servicio de Urología, Ciudad Sanitaria, Barcelona.
Actas Urologicas Espanolas
|September 1, 1994
Summary
Renal transplantation carries a low risk of de novo tumors, primarily affecting the skin, lung, kidney, and bladder. Early detection and treatment of these tumors are crucial for patient outcomes.
Area of Science:
- Nephrology
- Oncology
- Transplant Surgery
Context:
- Renal transplantation involves managing potential risks, including oncological complications.
- Understanding de novo tumor development post-transplant is critical for long-term patient survival.
Purpose:
- To analyze the incidence and types of de novo tumors in renal transplant recipients.
- To identify etiological factors contributing to tumor development after transplantation.
- To present findings from a urotransplantation meeting on oncology and renal transplantation.
Summary:
- A study of 661 renal transplantations identified de novo tumors in 4.4% of patients, with skin, lung, kidney, and bladder being the most common sites.
- Potential tumor migration from elderly donors was noted as a high-risk factor.
- Recipient factors included older age, immunosuppression, viral infections, and environmental agents.
Impact:
- Skin lesions responded well to local treatment without immunosuppression cessation.
- Highlights the importance of vigilant oncological surveillance in renal transplant recipients.
- Informs clinical practice regarding de novo tumor management post-renal transplantation.